Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Annals of Medicine|August 3, 2026
Selinexor combined bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma with high-risk factors: a single-arm, multi-center, prospective observational clinical studyJunjing Yin, Shuyuan Yu, Hongying Wu, et al.American Journal of Hematology|January 20, 2022
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled studyXiaofei Ni, Daqi Li, Chenglu Yuan, et al.Journal of Thrombosis and Haemostasis : JTH|January 6, 2024
E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopeniaLu Liu, Yujiao Xiang, Linlin Shao, et al.Blood|July 3, 2024
Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trialLu Sun, Xiaoyang Huang, Juan Wang, et al.American Journal of Hematology|October 9, 2019
A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopeniaHai Zhou, Ping Qin, Qiang Liu, et al.Inorganic Chemistry|May 30, 2026
Noncoordinating Substituent Modulation Strategy Lights Up Uranyl Organic Complexes for Sensitive X-ray Detection and ImagingYang Yang, Zhiyong Peng, Benxian Huang, et al.The Lancet. Haematology|March 26, 2021
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trialLu Sun, Juan Wang, Linlin Shao, et al.Annals of Hematology|September 12, 2023
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world studyMeng Wu, Fengrong Wang, Shihua Zhao, et al.Leukemia & Lymphoma|December 18, 2019
1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomibChenxing Du, Xuehan Mao, Yan Xu, et al.Blood Advances|October 10, 2019
The impact of response kinetics for multiple myeloma in the era of novel agentsYuting Yan, Xuehan Mao, Jiahui Liu, et al.Pageof 3